SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 77 filers reported holding SYNTA PHARMACEUTICALS CORP in Q4 2013. The put-call ratio across all filers is 0.94 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,000 | – | 4,000 | +100.0% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 2,000 | -20.0% | 0.00% | – |
| Q4 2015 | $1,000 | -95.5% | 2,500 | -80.6% | 0.00% | – |
| Q3 2015 | $22,000 | -52.2% | 12,911 | -37.8% | 0.00% | – |
| Q2 2015 | $46,000 | -51.1% | 20,766 | -57.3% | 0.00% | – |
| Q1 2015 | $94,000 | -18.3% | 48,603 | +12.2% | 0.00% | – |
| Q4 2014 | $115,000 | -48.4% | 43,319 | -41.6% | 0.00% | – |
| Q3 2014 | $223,000 | +443.9% | 74,181 | +641.8% | 0.00% | – |
| Q2 2014 | $41,000 | -21.2% | 10,000 | -16.7% | 0.00% | – |
| Q1 2014 | $52,000 | +160.0% | 12,000 | +287.0% | 0.00% | – |
| Q3 2013 | $20,000 | +33.3% | 3,101 | +3.4% | 0.00% | – |
| Q2 2013 | $15,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 21,704,847 | $5,209,000 | 7.19% |
| CAXTON CORP | 67,000 | $16,000 | 0.02% |
| McQueen, Ball & Associates Inc. | 102,742 | $25,000 | 0.02% |
| TWO SIGMA SECURITIES, LLC | 36,056 | $9,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,398,330 | $336,000 | 0.01% |
| WEDBUSH SECURITIES INC | 45,000 | $11,000 | 0.00% |
| Roundview Capital LLC | 21,100 | $5,000 | 0.00% |
| Renaissance Technologies | 2,332,995 | $560,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 618,599 | $148,000 | 0.00% |
| Virtu KCG Holdings LLC | 107,071 | $26,000 | 0.00% |